Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04912180 · ClinicalTrials.gov registry record
Apple Respiratory Study
A clinical trial, sponsored by Apple.
- Terminated
- Registry status
- 108
- Enrollment target
NCT04912180 is a clinical trial that was terminated before completion, run by Apple. The registered enrollment target is 108 participants.
The verdict
NCT04912180 was terminated before completion, sponsored by Apple.
- TERMINATED
- Registry status
- 108 participants
- Enrollment target
Study Summary
The Apple Respiratory Study, a collaboration between researchers at Apple Inc. (the "Study Sponsor" or "Sponsor") and the Seattle Flu Study team at the University of Washington (UW) (the "UW Study Team"), is a prospective, longitudinal cohort, low risk Study to collect certain data from Apple Watch and iPhone to determine whether such data can detect physiologic and non-physiologic changes in individuals associated with respiratory illnesses due to influenza, SARS-CoV-2 and other respiratory pathogens (the "Study").
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-04-06 |
| Est. Completion | 2021-06-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04912180
The ClinicalTrials.gov registry entry for NCT04912180 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04912180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04912180 about?
NCT04912180 is a clinical study titled "Apple Respiratory Study". The Apple Respiratory Study, a collaboration between researchers at Apple Inc. (the "Study Sponsor" or "Sponsor") and the Seattle Flu Study team at the University of Washington (UW) (the "UW Study Team"), is a prospective, longitudinal cohort, low risk Study to collect certain data from Apple Watch ...
What is the current status of trial NCT04912180?
This trial is currently terminated. The enrollment target is 108 participants. The study started on 2021-04-06. Estimated completion is 2021-06-09.
Who is sponsoring clinical trial NCT04912180?
This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.